RS

Ramakanta Samantaray

Director Director DIN 07818890
DIN 07818890 First appointment Jun 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramakanta Samantaray

Data last updated:

Ramakanta Samantaray was a Director at Arundaya Medicare Private Limited (2018–2022) and Director at Sayro Health Remedies Private Limited (from 2017). The companies operate in Pharma.

DIN 07818890
Primary Designation Director
Industry Pharma
First Appointment 16 Jun 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arundaya Medicare Private Limited U52609OR2018PTC028896
Director18 May 20182018₹56.2 Lakh (FY 2025)Active
Director16 Jun 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sayro Health Remedies Private Limited
Arundaya Medicare Private Limited
Premium access

Shareholding and investment profile for Ramakanta Samantaray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakanta Samantaray

Ramakanta Samantaray was first appointed on 16 Jun 2017 as Director at Sayro Health Remedies Private Limited. The most recent appointment on record is 18 May 2018 at Arundaya Medicare Private Limited.

Ramakanta Samantaray held 2 earlier board appointments: Arundaya Medicare Private Limited (Director, 18 May 2018 to 30 Sep 2022); Sayro Health Remedies Private Limited (Director, from 16 Jun 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available